Gary J. Nabel
CIK: 0001867450
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Jun 23, 2026CADL
Candel Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
32K shares- - Jun 9, 2026SIGA
SIGA TECHNOLOGIES INC
Award(A)DirectRestricted Stock Units
34.2K shares- - Jun 9, 2026SIGA
SIGA TECHNOLOGIES INC
Exercise(M)Direct24.1K shares- - Jun 9, 2026SIGA
SIGA TECHNOLOGIES INC
Disposition(D)Direct7.2K shares at avg. $4.39$32K - Jun 25, 2025CADL
Candel Therapeutics, Inc.
Award(A)Direct5.4K shares at avg. $4.67$25K - Jun 17, 2025CADL
Candel Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
14.2K shares- - Jun 10, 2025SIGA
SIGA TECHNOLOGIES INC
Disposition(D)Direct5.7K shares at avg. $6.22$36K - Jun 10, 2025SIGA
SIGA TECHNOLOGIES INC
Exercise(M)Direct19.1K shares- - Jun 10, 2025SIGA
SIGA TECHNOLOGIES INC
Award(A)DirectRestricted Stock Units
24.1K shares- - May 27, 2025OPK
OPKO HEALTH, INC.
Award(A)DirectStock Option (Right to Buy)
437.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 23, 2026 |  CADL Candel Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 32,000 | - | - | Direct |
| Jun 9, 2026 |  SIGA SIGA TECHNOLOGIES INC | Award(A) Restricted Stock Units | 34,169 | - | - | Direct |
| Jun 9, 2026 | SIGA SIGA TECHNOLOGIES INC | Exercise(M) | 24,116 | - | $0 | Direct |
| Jun 9, 2026 | SIGA SIGA TECHNOLOGIES INC | Disposition(D) | 7,235 | $4.39 | $31,762 | Direct |
| Jun 25, 2025 | CADL Candel Therapeutics, Inc. | Award(A) | 5,353 | $4.67 | $24,999 | Direct |
| Jun 17, 2025 | CADL Candel Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 14,240 | - | - | Direct |
| Jun 10, 2025 | SIGA SIGA TECHNOLOGIES INC | Disposition(D) | 5,725 | $6.22 | $35,610 | Direct |
| Jun 10, 2025 | SIGA SIGA TECHNOLOGIES INC | Exercise(M) | 19,084 | - | - | Direct |
| Jun 10, 2025 | SIGA SIGA TECHNOLOGIES INC | Award(A) Restricted Stock Units | 24,116 | - | - | Direct |
| May 27, 2025 |  OPK OPKO HEALTH, INC. | Award(A) Stock Option (Right to Buy) | 437,500 | - | - | Direct |
1-10 of 10 transactions
About Nabel Gary J.
Nabel Gary J. (SEC CIK 0001867450) files insider reports with the SEC as Director of Candel Therapeutics, Inc. (CADL), Director of SIGA TECHNOLOGIES INC (SIGA) and Chief Innovation Officer of OPKO HEALTH, INC. (OPK).
Signal8 holds 6 ownership filings by Nabel Gary J., all Form 4s, filed between May 29, 2025 and Jun 24, 2026. Those filings report 10 transactions, from May 27, 2025 to Jun 23, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Nabel Gary J.'s filings is in NEW YORK, NY.
Recent filings by Nabel Gary J.
- Jun 23, 2026: Grant or award of CADL derivative securities (Form 4, code A).
- Jun 9, 2026: Grant or award of SIGA derivative securities (Form 4, code A).
- Jun 9, 2026: Option exercise of SIGA shares (Form 4, code M).
- Jun 9, 2026: Disposition to issuer transaction of SIGA shares (Form 4, code D).
- Jun 25, 2025: Grant or award of CADL shares (Form 4, code A).
Other insiders filing for Candel Therapeutics, Inc. (CADL)
- Loggia Nicoletta, Director
- PAPA JOSEPH C, Director
- Manning Paul B, Director
- Tak Paul Peter, Chief Executive Officer
- Zimmermann Martine, Director
- Tyagarajan Seshu, Chief Technology Officer